Patient-specific simulation of transcatheter aortic valve replacement: impact of deployment options on paravalvular leakage.


Journal

Biomechanics and modeling in mechanobiology
ISSN: 1617-7940
Titre abrégé: Biomech Model Mechanobiol
Pays: Germany
ID NLM: 101135325

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 23 08 2018
accepted: 01 11 2018
pubmed: 22 11 2018
medline: 12 7 2019
entrez: 22 11 2018
Statut: ppublish

Résumé

Transcatheter aortic valve replacement (TAVR) has emerged as an effective alternative to conventional surgical valve replacement in high-risk patients afflicted by severe aortic stenosis. Despite newer-generation devices enhancements, post-procedural complications such as paravalvular leakage (PVL) and related thromboembolic events have been hindering TAVR expansion into lower-risk patients. Computational methods can be used to build and simulate patient-specific deployment of transcatheter aortic valves (TAVs) and help predict the occurrence and degree of PVL. In this study finite element analysis and computational fluid dynamics were used to investigate the influence of procedural parameters on post-deployment hemodynamics on three retrospective clinical cases affected by PVL. Specifically, TAV implantation depth and balloon inflation volume effects on stent anchorage, degree of paravalvular regurgitation and thrombogenic potential were analyzed for cases in which Edwards SAPIEN and Medtronic CoreValve were employed. CFD results were in good agreement with corresponding echocardiography data measured in patients in terms of the PVL jets locations and overall PVL degree. Furthermore, parametric analyses demonstrated that positioning and balloon over-expansion may have a direct impact on the post-deployment TAVR performance, achieving as high as 47% in PVL volume reduction. While the model predicted very well clinical data, further validation on a larger cohort of patients is needed to verify the level of the model's predictions in various patient-specific conditions. This study demonstrated that rigorous and realistic patient-specific numerical models could potentially serve as a valuable tool to assist physicians in pre-operative TAVR planning and TAV selection to ultimately reduce the risk of clinical complications.

Identifiants

pubmed: 30460623
doi: 10.1007/s10237-018-1094-8
pii: 10.1007/s10237-018-1094-8
pmc: PMC6476328
mid: NIHMS1014207
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

435-451

Subventions

Organisme : National Institute of Biomedical Imaging and Bioengineering
ID : 1U01EB026414
Organisme : National Institute of Biomedical Imaging and Bioengineering
ID : 1U01EB012487
Organisme : NIBIB NIH HHS
ID : U01 EB026414
Pays : United States
Organisme : NHLBI NIH HHS
ID : R41 HL134418
Pays : United States
Organisme : NIBIB NIH HHS
ID : U01 EB012487
Pays : United States

Commentaires et corrections

Type : ErratumIn

Références

JACC Cardiovasc Interv. 2016 Mar 14;9(5):508-12
pubmed: 26965945
JACC Cardiovasc Interv. 2012 May;5(5):540-551
pubmed: 22625193
J Biomech. 2016 Aug 16;49(12):2513-9
pubmed: 26748728
J Biomech. 2016 Sep 6;49(13):2824-2830
pubmed: 27395760
Comput Methods Biomech Biomed Engin. 2016;19(7):733-44
pubmed: 26194804
JACC Cardiovasc Imaging. 2015 Mar;8(3):340-60
pubmed: 25772838
Ann Transl Med. 2014 May;2(5):43
pubmed: 25333018
J Biomech Eng. 2018 Oct 1;140(10):
pubmed: 30029247
JACC Cardiovasc Interv. 2012 May;5(5):563-570
pubmed: 22625196
JACC Cardiovasc Interv. 2012 May;5(5):499-512
pubmed: 22625188
N Engl J Med. 2016 Apr 28;374(17):1609-20
pubmed: 27040324
PLoS One. 2016 Apr 22;11(4):e0153755
pubmed: 27104354
JACC Cardiovasc Interv. 2013 May;6(5):452-61
pubmed: 23602458
Catheter Cardiovasc Interv. 2018 Nov 1;92(5):972-980
pubmed: 29726601
Artif Organs. 2016 Dec;40(12):E292-E304
pubmed: 27911025
J Biomech. 2010 Aug 26;43(12):2400-9
pubmed: 20483411
World J Cardiol. 2017 Feb 26;9(2):196-199
pubmed: 28289535
J Am Coll Cardiol. 2015 Sep 22;66(12):1335-8
pubmed: 26383719
J Biomech Eng. 2014 Feb;136(2):021014
pubmed: 24337144
JACC Cardiovasc Interv. 2015 May;8(6):837-846
pubmed: 25999108
J Biomech. 2014 Aug 22;47(11):2547-55
pubmed: 24998989
Circulation. 2013 Jul 16;128(3):244-53
pubmed: 23748467
Mayo Clin Proc. 2018 Apr;93(4):488-508
pubmed: 29622096
EuroIntervention. 2016 Jan 22;11(9):1044-52
pubmed: 26788707
Catheter Cardiovasc Interv. 2011 Sep 1;78(3):432-43
pubmed: 21793168
Eur Heart J. 2016 Sep 07;37(34):2627-44
pubmed: 27075871
Curr Cardiol Rep. 2018 Aug 9;20(10):82
pubmed: 30094642
N Engl J Med. 2012 May 3;366(18):1686-95
pubmed: 22443479
Med Eng Phys. 2013 Jan;35(1):125-30
pubmed: 22640661
Eur Heart J. 2015 Feb 14;36(7):413-5
pubmed: 25336227
Expert Rev Med Devices. 2016;13(2):113-22
pubmed: 26679833
J Am Coll Cardiol. 2013 Mar 19;61(11):1125-36
pubmed: 23375925
Biomech Model Mechanobiol. 2019 Feb;18(1):79-88
pubmed: 30128675
Eur Radiol. 2014 Sep;24(9):2038-44
pubmed: 24816934
Biomech Model Mechanobiol. 2015 Jan;14(1):29-38
pubmed: 24736808
Ann Biomed Eng. 2013 Mar;41(3):577-86
pubmed: 23161165
J Biomech. 2017 Jun 14;58:114-122
pubmed: 28511838
J Biomech. 2017 Feb 28;53:22-28
pubmed: 28118978
Circulation. 2009 Jun 16;119(23):3009-16
pubmed: 19487594
J Biomech. 2018 Apr 11;71:236-244
pubmed: 29482928
PLoS One. 2012;7(3):e32463
pubmed: 22396768
J Thorac Cardiovasc Surg. 2018 Nov;156(5):1837-1848
pubmed: 29961588
Med Biol Eng Comput. 2012 Feb;50(2):183-92
pubmed: 22286953
JACC Cardiovasc Interv. 2015 Jan;8(1 Pt A):1-9
pubmed: 25616813
J Biomech. 2016 Aug 16;49(12):2520-30
pubmed: 27059259
Neuroimage. 2006 Jul 1;31(3):1116-28
pubmed: 16545965
Eur J Cardiothorac Surg. 2011 Jul;40(1):28-34
pubmed: 21177118
J Biomed Mater Res A. 2012 Jun;100(6):1591-9
pubmed: 22447518
J Biomech. 2012 Sep 21;45(14):2392-7
pubmed: 22854206
N Engl J Med. 2011 Jun 9;364(23):2187-98
pubmed: 21639811
Clin Res Cardiol. 2012 Jun;101(6):503-7
pubmed: 22476821
Nat Rev Cardiol. 2012 May 01;9(8):454-63
pubmed: 22547171
J Biomech. 2015 Sep 18;48(12):3026-34
pubmed: 26294354

Auteurs

Matteo Bianchi (M)

Department of Biomedical Engineering, Stony Brook University, T15-090 Health Sciences Center, Stony Brook, NY, 11794-8151, USA.

Gil Marom (G)

Department of Biomedical Engineering, Stony Brook University, T15-090 Health Sciences Center, Stony Brook, NY, 11794-8151, USA.
School of Mechanical Engineering, Tel Aviv University, Tel Aviv, Israel.

Ram P Ghosh (RP)

Department of Biomedical Engineering, Stony Brook University, T15-090 Health Sciences Center, Stony Brook, NY, 11794-8151, USA.

Oren M Rotman (OM)

Department of Biomedical Engineering, Stony Brook University, T15-090 Health Sciences Center, Stony Brook, NY, 11794-8151, USA.

Puja Parikh (P)

Division of Cardiovascular Diseases, Stony Brook University Hospital, Stony Brook, NY, USA.

Luis Gruberg (L)

Division of Cardiology, Southside Hospital, Northwell Health, Bay Shore, NY, USA.

Danny Bluestein (D)

Department of Biomedical Engineering, Stony Brook University, T15-090 Health Sciences Center, Stony Brook, NY, 11794-8151, USA. danny.bluestein@stonybrook.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH